- Report
- May 2024
- 200 Pages
Global
From €3768EUR$4,150USD£3,164GBP
- Report
- September 2021
- 246 Pages
Global
From €4040EUR$4,450USD£3,393GBP
- Report
- November 2023
- 150 Pages
Global
From €4040EUR$4,450USD£3,393GBP
- Report
- February 2022
- 198 Pages
Global
From €4040EUR$4,450USD£3,393GBP
- Report
- February 2025
- 197 Pages
India
From €2270EUR$2,500USD£1,906GBP
- Report
- October 2023
- 171 Pages
Global
From €2270EUR$2,500USD£1,906GBP
- Report
- February 2024
- 110 Pages
Global
From €4313EUR$4,750USD£3,621GBP
- Report
- February 2024
- 147 Pages
Global
From €4313EUR$4,750USD£3,621GBP
- Report
- February 2024
- 111 Pages
Global
From €4313EUR$4,750USD£3,621GBP
- Report
- August 2022
- 112 Pages
Global
From €4313EUR$4,750USD£3,621GBP
- Report
- January 2022
- 115 Pages
Global
From €4313EUR$4,750USD£3,621GBP
- Report
- January 2022
- 114 Pages
Global
From €4313EUR$4,750USD£3,621GBP
- Report
- May 2024
- 186 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- April 2024
- 187 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- April 2024
- 183 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- April 2024
- 182 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- April 2024
- 180 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- February 2024
- 171 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- September 2023
- 118 Pages
Global
From €4086EUR$4,500USD£3,431GBP
- Report
- July 2022
- 280 Pages
Global
From €3269EUR$3,600USD£2,745GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more